RS56006B1 - Korišćenje inhibitora il-18 za lečenje ili prevenciju povreda cns - Google Patents
Korišćenje inhibitora il-18 za lečenje ili prevenciju povreda cnsInfo
- Publication number
- RS56006B1 RS56006B1 YU89403A YUP89403A RS56006B1 RS 56006 B1 RS56006 B1 RS 56006B1 YU 89403 A YU89403 A YU 89403A YU P89403 A YUP89403 A YU P89403A RS 56006 B1 RS56006 B1 RS 56006B1
- Authority
- RS
- Serbia
- Prior art keywords
- inhibitors
- treating
- cns injuries
- preventing cns
- injuries
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000006378 damage Effects 0.000 title 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000001738 Nervous System Trauma Diseases 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Ovaj pronalazak se odnosi na korišćenje inhibitora IL-18 za pripremu medikamenta za lečenje i/ili prevenciju povreda centralnog nervnog sistema a pre svega traumatske povrede glave.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01112067 | 2001-05-25 | ||
| PCT/EP2002/005666 WO2002096456A1 (en) | 2001-05-25 | 2002-05-23 | Use of il-18 inhibitors for treating or preventing cns injuries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU89403A YU89403A (sh) | 2006-05-25 |
| RS56006B1 true RS56006B1 (sr) | 2017-09-29 |
Family
ID=8177454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU89403A RS56006B1 (sr) | 2001-05-25 | 2002-05-23 | Korišćenje inhibitora il-18 za lečenje ili prevenciju povreda cns |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7655616B2 (sr) |
| EP (1) | EP1390070B1 (sr) |
| JP (1) | JP4344142B2 (sr) |
| KR (1) | KR20040030625A (sr) |
| CN (1) | CN1305529C (sr) |
| AU (1) | AU2002314103B2 (sr) |
| BG (1) | BG66395B1 (sr) |
| BR (1) | BR0210007A (sr) |
| CA (1) | CA2445664C (sr) |
| CY (1) | CY1119190T1 (sr) |
| CZ (1) | CZ307321B6 (sr) |
| DK (1) | DK1390070T3 (sr) |
| EA (1) | EA006744B1 (sr) |
| EE (1) | EE05263B1 (sr) |
| ES (1) | ES2617084T3 (sr) |
| HK (1) | HK1069762A1 (sr) |
| HR (1) | HRP20030842B1 (sr) |
| HU (1) | HU230294B1 (sr) |
| IL (2) | IL159014A0 (sr) |
| LT (1) | LT1390070T (sr) |
| ME (1) | ME00550B (sr) |
| MX (1) | MXPA03010743A (sr) |
| NO (1) | NO331882B1 (sr) |
| PL (1) | PL216228B1 (sr) |
| PT (1) | PT1390070T (sr) |
| RS (1) | RS56006B1 (sr) |
| SK (1) | SK288413B6 (sr) |
| UA (1) | UA80396C2 (sr) |
| WO (1) | WO2002096456A1 (sr) |
| ZA (1) | ZA200308172B (sr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5074030B2 (ja) | 2003-05-13 | 2012-11-14 | メルク セローノ ソシエテ アノニム | Ｉｌ−１８結合タンパク質の活性変異体とその医学的応用 |
| WO2006003927A1 (ja) * | 2004-06-30 | 2006-01-12 | Atsuo Sekiyama | 非炎症性ストレス応答の指標剤およびその利用 |
| DK2267024T3 (da) | 2005-06-03 | 2012-06-25 | Ares Trading Sa | Fremstilling af rekombinant II-18 bindingsprotein |
| JP5048658B2 (ja) * | 2005-06-03 | 2012-10-17 | メルク セローノ ソシエテ アノニム | 神経性炎症性疾患の治療、及び／又は予防のためのｉｌ−１８ｂｐアイソフォームの使用 |
| PL1891088T3 (pl) | 2005-06-10 | 2012-03-30 | Ares Trading Sa | Sposób oczyszczania białka wiążącego IL-18 |
| US8685400B2 (en) | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| MX2016002719A (es) * | 2013-09-05 | 2016-09-06 | Ab2 Bio Sa | Proteina de union a interleucina 18 (il-18bp) en enfermedades inflamatorias. |
| MY194040A (en) | 2015-03-05 | 2022-11-09 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0873453A (ja) * | 1994-09-02 | 1996-03-19 | Otsuka Pharmaceut Co Ltd | サイトカイン阻害剤 |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| WO1999046248A1 (en) * | 1998-03-09 | 1999-09-16 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| UA87658C2 (uk) * | 2000-05-05 | 2009-08-10 | Апплайд Резеч Системз Арс Холдинг Н.В. | Застосування il-18 як діагностичного маркера серцевої недостатності |
| AU2001266289A1 (en) * | 2000-06-23 | 2002-01-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| US6671553B1 (en) * | 2001-05-23 | 2003-12-30 | Pacesetter, Inc. | Implantable cardiac lead having terminating connector strain relief and method of manufacture |
-
2002
- 2002-05-23 KR KR10-2003-7015310A patent/KR20040030625A/ko active Search and Examination
- 2002-05-23 HU HU0304067A patent/HU230294B1/hu unknown
- 2002-05-23 SK SK1603-2003A patent/SK288413B6/sk not_active IP Right Cessation
- 2002-05-23 EP EP02740641.2A patent/EP1390070B1/en not_active Expired - Lifetime
- 2002-05-23 ES ES02740641.2T patent/ES2617084T3/es not_active Expired - Lifetime
- 2002-05-23 UA UA20031212328A patent/UA80396C2/uk unknown
- 2002-05-23 EA EA200301299A patent/EA006744B1/ru not_active IP Right Cessation
- 2002-05-23 ME MEP-2008-618A patent/ME00550B/me unknown
- 2002-05-23 PL PL367545A patent/PL216228B1/pl unknown
- 2002-05-23 IL IL15901402A patent/IL159014A0/xx unknown
- 2002-05-23 AU AU2002314103A patent/AU2002314103B2/en not_active Expired
- 2002-05-23 CZ CZ2003-3268A patent/CZ307321B6/cs not_active IP Right Cessation
- 2002-05-23 LT LTEP02740641.2T patent/LT1390070T/lt unknown
- 2002-05-23 BR BR0210007-0A patent/BR0210007A/pt not_active Application Discontinuation
- 2002-05-23 EE EEP200300582A patent/EE05263B1/xx unknown
- 2002-05-23 WO PCT/EP2002/005666 patent/WO2002096456A1/en active IP Right Grant
- 2002-05-23 DK DK02740641.2T patent/DK1390070T3/en active
- 2002-05-23 US US10/478,614 patent/US7655616B2/en not_active Expired - Lifetime
- 2002-05-23 CA CA2445664A patent/CA2445664C/en not_active Expired - Lifetime
- 2002-05-23 JP JP2002592965A patent/JP4344142B2/ja not_active Expired - Lifetime
- 2002-05-23 RS YU89403A patent/RS56006B1/sr unknown
- 2002-05-23 CN CNB028147510A patent/CN1305529C/zh not_active Expired - Lifetime
- 2002-05-23 MX MXPA03010743A patent/MXPA03010743A/es active IP Right Grant
- 2002-05-23 PT PT2740641T patent/PT1390070T/pt unknown
-
2003
- 2003-10-17 HR HRP20030842AA patent/HRP20030842B1/hr not_active IP Right Cessation
- 2003-10-21 ZA ZA200308172A patent/ZA200308172B/xx unknown
- 2003-11-20 NO NO20035160A patent/NO331882B1/no not_active IP Right Cessation
- 2003-11-23 IL IL159014A patent/IL159014A/en active IP Right Grant
- 2003-12-15 BG BG108451A patent/BG66395B1/bg unknown
-
2004
- 2004-12-31 HK HK04110391A patent/HK1069762A1/xx not_active IP Right Cessation
-
2017
- 2017-05-08 CY CY20171100494T patent/CY1119190T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112932T1 (el) | Αναστολεις sμαd7 για τη θεραπευτικη αγωγη ασθενειων του κνς | |
| RS50091B (sr) | Upotreba retigabina u lečenju neuropatskog bola | |
| HUP0303363A2 (hu) | Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására | |
| GB0108770D0 (en) | Inhibitors | |
| YU12097A (en) | 6-phenilpyridyl-2-amine derivatives | |
| IL157652A (en) | Metalloproteinase inhibitors, compositions comprising them and uses thereof for the preparation of medicaments for treating diseases or conditions mediated by metalloproteinase enzymes | |
| PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
| NO20024005D0 (no) | Pteridinforbindelser for behandling av psoriasis | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| CY1119190T1 (el) | Χρηση αναστολεων της il-18 για αγωγη ή προληψη βλαβων του κνς | |
| HRP20070552T3 (en) | Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders | |
| ME00554B (me) | KORIŠĆENJE IL-18 INHIBITORA ZA LIJEČENJE l/ILI PREVENCIJU ATEROSKLEROZE | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| ME00549B (me) | Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja | |
| DE60329326D1 (de) | Tace inhibitoren | |
| IL161116A0 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
| MXPA04001205A (es) | Compuesto para eliminar y/o mitigar la anhedonia. | |
| HRP20040071B1 (hr) | Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti | |
| BR0314364A (pt) | Uso de inibidores de pde iv para tratar angiogênese | |
| MY141975A (en) | Pyridyl substituted heterocycles useful for treating or preventing hcv infection |